AAO Decisions Explorer · Free
Published AAO appeal decisions
Search the decisions the Administrative Appeals Office has published, narrow them by visa, criterion, field and year, and read our summary of each one with a link to the official PDF.

Decisions in the library
6,586
6,586 classified
Visa types
3
Years covered
2005-2026
Latest decision
Aug 31, 2026
Filters
67 decisions
Outcomes in these results
- Dismissed
- Remanded
- Sustained
- EB-2 NIWBiotech and pharmaNov 2025Dismissed
Clinical laboratory scientist proposes AI forecasting models to address blood-bank shortages. AAO held endeavor has national importance but petitioner not well positioned to advance it: lacks demonstrated AI capabilities, formal machine learning education, and progress evidence despite prior statistics coursework and media attention.
1 of 3 criteria metRead → - EB-1ABiotech and pharmaSep 2025Dismissed
A biomedical textiles and materials engineer seeks extraordinary ability classification. Met two of ten initial evidence criteria regarding salary and commercial success but failed membership and original contributions prongs. Decision held that meeting only two criteria does not satisfy the threshold initial evidence requirement; final merits analysis was reserved.
2 of 5 criteria metRead → - EB-1ABiotech and pharmaAug 2025Dismissed
A postdoctoral bioelectronics researcher specializing in protein nanowires sought EB-1A extraordinary ability classification. The AAO dismissed the appeal, finding the petitioner met only two of three claimed criteria and failed to demonstrate original contributions of major significance, falling short of the three-criterion threshold.
2 of 11 criteria metRead → - EB-2 NIWBiotech and pharmaJul 2025Dismissed
Postdoctoral fellow in biomedical research sought EB-2 NIW with advanced degree. Proposed cancer research endeavor met substantial merit and national importance, but AAO found petitioner not well positioned to advance it: lacking significant funded grant record, evidence of work adoption by others, or comprehensive future plan despite strong academic credentials.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJun 2025Dismissed
A medical scientist sought EB-2 classification with national interest waiver for a biomedical research and clinical diagnostics endeavor. The AAO affirmed dismissal, holding the petitioner failed to demonstrate national importance under Dhanasar's first prong, showing only individualized benefits to clients and employees rather than broader field or regional impact.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJun 2025Dismissed
Business development manager in pharmaceutical sector seeks EB-2 NIW. SCOPS found petitioner qualified for EB-2 and met second Dhanasar prong. AAO held first prong unmet because petitioner conflated general field importance with specific endeavor's national importance; no prospective impact directly attributable to petitioner's work.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJun 2025Dismissed
Biomedical scientist with Ph.D. sought NIW for postdoctoral research on nanomembranes for cancer treatment. AAO found substantial merit and national importance but dismissed appeal because petitioner failed to demonstrate she was well-positioned to advance the endeavor through lack of sustained funding, clear research plan, or stakeholder interest.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaMay 2025Dismissed
Biomedical scientist sought EB-2 with national interest waiver for genetic research on medical conditions. AAO found petitioner failed to establish advanced degree eligibility due to translation deficiencies and did not demonstrate national importance of proposed endeavor, lacking specific prospective impact evidence.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaMay 2025Dismissed
Engineer and researcher in clinical tissue engineering and transplantation seeking EB-2 advanced degree classification and national interest waiver. AAO affirmed that petitioner qualified as advanced degree professional but dismissed appeal because petitioner failed to demonstrate being well-positioned to advance proposed endeavor; education and publications insufficient without demonstrated record of success.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaApr 2025Dismissed
A biomedical researcher with a PhD in immunology sought EB-2 NIW classification for research on genome and protein engineering. The AAO agreed he met EB-2 requirements but found his specific proposed endeavor lacked national importance despite involving critical emerging technologies, as expert letters discussed his field generally, not his particular research.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaMar 2025Dismissed
Medical scientist seeking EB-2 NIW for cancer research endeavor. Claimed substantial merit and national importance through publications, recommendations, and funding. AAO held proposed work lacks demonstrated national importance because specific endeavor's broader field implications were not established; general cancer information insufficient.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaMar 2025Dismissed
Biomedical systems technician seeks NIW to establish business providing clinical engineering services, equipment maintenance, and training. AAO dismissed appeal, finding the petitioner failed to demonstrate national importance of the proposed endeavor, lacking evidence of substantial economic impact, job creation, or industry-wide implications beyond prospective clients.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaFeb 2025Dismissed
A biomedical scientist and clinical pathology technician sought EB-2 with national interest waiver. The AAO dismissed the appeal, holding that the proposed biomedical company's services and training would not extend beyond individual clients to have national importance or broader field impact.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaFeb 2025Dismissed
Pharmaceutical sales representative with advanced degree seeks EB-2 national interest waiver for health-related project. Petitioner claimed national importance through health and economic benefits. AAO held substantial merit shown but national importance unmet; endeavor lacks evidence of broader field or regional impact exceeding specific occupational role.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaNov 2024Dismissed
Biomedical engineer researcher proposed postdoctoral research on brain cognitive processes using machine learning. AAO withdrew denial of prong one, finding national importance, but affirmed denial under prong two because petitioner lacked demonstrated influence or record of success advancing the field.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaSep 2024Dismissed
Researcher with advanced degree seeking national interest waiver to develop biomedical instruments and enhance ECMO technology. Director and AAO found petitioner failed to establish that specific proposed endeavor has national importance, focusing on industry importance rather than endeavor-specific prospective impact.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaAug 2024Dismissed
A bioengineer and prosthetics researcher sought EB-2 classification with a national interest waiver. The AAO dismissed the appeal, finding she failed to establish a U.S. bachelor's or advanced degree equivalent and, even under exceptional ability, did not meet three evidentiary criteria. The proposed endeavor lacked specific evidence of national importance.
0 of 3 criteria metRead → - EB-1ABiotech and pharmaAug 2024Dismissed
Pharmaceutical microbiology production manager seeking EB-1A extraordinary ability classification. AAO found petitioner did not meet initial evidence requirements; failed to establish three alternate criteria. Awards lacked documented recognition for field excellence; published material insufficient; no sustained national or international acclaim demonstrated.
0 of 11 criteria metRead → - EB-2 NIWBiotech and pharmaAug 2024Dismissed
Bioanalyst and high school teacher seeking NIW for consulting business in bioanalysis and STEM education. Claimed endeavor would advance science education and economic growth. AAO dismissed appeal, finding proposed endeavor lacked national importance and petitioner not well-positioned to advance it.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJul 2024Dismissed
A pharmaceutical industrial production manager sought EB-2 classification with national interest waiver to plan and direct manufacturing operations. The AAO found the proposed endeavor had substantial merit but lacked national importance, as providing services for one employer would not generate significant economic activity or employment potential at national scale.
0 of 3 criteria metRead → - EB-1ABiotech and pharmaJul 2024Dismissed
A biomedical engineer researcher sought EB-1A classification. The AAO affirmed that he met three initial criteria but dismissed his appeal, finding he failed to demonstrate sustained national or international acclaim or that he ranks among the very top of his field despite accomplishments.
3 of 4 criteria metRead → - EB-2 NIWBiotech and pharmaApr 2024Dismissed
Pharmacist and entrepreneur sought NIW to operate business providing parenteral nutrition products. AAO affirmed denial, finding petitioner failed to describe proposed endeavor with sufficient specificity and provide corroborating evidence that business activities would achieve substantial national economic impact.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaMar 2024Dismissed
Bioengineering technology researcher seeking NIW for EB-2. AAO agreed endeavor has national importance but held she is not well-positioned to advance it because her research lacks substantial citations, field impact, and evidence of obtaining funding, failing the second Dhanasar prong.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaFeb 2024Dismissed
Pharmaceutical professional seeking EB-2 exceptional ability classification and national interest waiver. AAO dismissed appeal because petitioner failed to meet three initial evidentiary criteria for exceptional ability and did not establish specific endeavor or its prospective national importance under Dhanasar framework.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJan 2024Dismissed
An entrepreneur with pharmacy and diagnostic laboratory expertise seeks EB-2 NIW to open a low-cost diagnostic lab in an economically depressed region. AAO dismissed because the proposed endeavor lacks national importance; a small business serving local patients and employing 22 workers does not meet Dhanasar's requirement for broader field impact or substantial national economic benefit.
0 of 3 criteria metRead →
